Howard Bregman

3.2k total citations
31 papers, 1.7k citations indexed

About

Howard Bregman is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Howard Bregman has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Organic Chemistry and 12 papers in Oncology. Recurrent topics in Howard Bregman's work include Ferrocene Chemistry and Applications (7 papers), Metal complexes synthesis and properties (7 papers) and Wnt/β-catenin signaling in development and cancer (6 papers). Howard Bregman is often cited by papers focused on Ferrocene Chemistry and Applications (7 papers), Metal complexes synthesis and properties (7 papers) and Wnt/β-catenin signaling in development and cancer (6 papers). Howard Bregman collaborates with scholars based in United States, United Kingdom and Switzerland. Howard Bregman's co-authors include Eric Meggers, Douglas S. Williams, Nicholas Pagano, Patrick J. Carroll, G. Ekin Atilla‐Gokcumen, Yanan Zhang, Scott T. Handy, Stefan Knapp, J.E. Debreczeni and Alex N. Bullock and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Howard Bregman

30 papers receiving 1.7k citations

Peers

Howard Bregman
Jasna Maksimoska United States
Joel C. Barrish United States
Benoı̂t Joseph France
Brian E. Fink United States
Hsueh‐Yun Lee Taiwan
Tao Lu China
Wu Du United States
Pascale Moreau France
Pier F. Cirillo United States
Ji‐Wang Chern Taiwan
Jasna Maksimoska United States
Howard Bregman
Citations per year, relative to Howard Bregman Howard Bregman (= 1×) peers Jasna Maksimoska

Countries citing papers authored by Howard Bregman

Since Specialization
Citations

This map shows the geographic impact of Howard Bregman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Bregman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Bregman more than expected).

Fields of papers citing papers by Howard Bregman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Bregman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Bregman. The network helps show where Howard Bregman may publish in the future.

Co-authorship network of co-authors of Howard Bregman

This figure shows the co-authorship network connecting the top 25 collaborators of Howard Bregman. A scholar is included among the top collaborators of Howard Bregman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard Bregman. Howard Bregman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Metz, Peter, Howard Bregman, Rishi G. Vaswani, et al.. (2025). Highly Selective and Reversible STAT6 Inhibition Demonstrates Potential for Differentiated Efficacy and Safety Profile in Type 2 Allergic Inflammation. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1319–A1319. 2 indexed citations
2.
3.
Andrews, Kristin L., Loren Berry, Howard Bregman, et al.. (2017). Applications of parallel synthetic lead hopping and pharmacophore-based virtual screening in the discovery of efficient glycine receptor potentiators. European Journal of Medicinal Chemistry. 137. 63–75. 10 indexed citations
4.
Huang, Xin, P.L. Shaffer, Howard Bregman, et al.. (2016). Crystal structures of human glycine receptor α3 bound to a novel class of analgesic potentiators. Nature Structural & Molecular Biology. 24(2). 108–113. 99 indexed citations
5.
Liu, Longbin, Matthew R. Lee, Joseph L. Kim, et al.. (2016). Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling. Bioorganic & Medicinal Chemistry. 24(10). 2215–2234. 13 indexed citations
6.
Sparling, Brian A., Jessica Able, Howard Bregman, et al.. (2016). Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent NaV1.7 inhibitors. MedChemComm. 8(4). 744–754. 4 indexed citations
7.
8.
Bregman, Howard, Hakan Günaydin, Yan Gu, et al.. (2013). Discovery of a Class of Novel Tankyrase Inhibitors that Bind to Both the Nicotinamide Pocket and the Induced Pocket. Journal of Medicinal Chemistry. 56(3). 1341–1345. 40 indexed citations
9.
Bregman, Howard, Hanh Nho Nguyen, Joseph Ligutti, et al.. (2012). The discovery of aminopyrazines as novel, potent Nav1.7 antagonists: Hit-to-lead identification and SAR. Bioorganic & Medicinal Chemistry Letters. 22(5). 2033–2042. 12 indexed citations
10.
Hua, Zihao, Xin Huang, Howard Bregman, et al.. (2012). 2-Phenylamino-6-cyano-1H-benzimidazole-based isoform selective casein kinase 1 gamma (CK1γ) inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(17). 5392–5395. 20 indexed citations
11.
Bullock, Alex N., A. Amos, Nicholas Pagano, et al.. (2009). Crystal Structure of the PIM2 Kinase in Complex with an Organoruthenium Inhibitor. PLoS ONE. 4(10). e7112–e7112. 79 indexed citations
12.
Smalley, Keiran S.M., Rooha Contractor, Nikolas K. Haass, et al.. (2007). An Organometallic Protein Kinase Inhibitor Pharmacologically Activates p53 and Induces Apoptosis in Human Melanoma Cells. Cancer Research. 67(1). 209–217. 176 indexed citations
13.
Pagano, Nicholas, Jasna Maksimoska, Howard Bregman, et al.. (2007). Ruthenium half-sandwich complexes as protein kinase inhibitors: derivatization of the pyridocarbazole pharmacophore ligand. Organic & Biomolecular Chemistry. 5(8). 1218–1218. 63 indexed citations
14.
Meggers, Eric, G. Ekin Atilla‐Gokcumen, Howard Bregman, et al.. (2007). Exploring Chemical Space with Organometallics: Ruthenium Complexes as Protein Kinase Inhibitors. ChemInform. 38(31). 1 indexed citations
15.
Debreczeni, J.E., Alex N. Bullock, Douglas S. Williams, et al.. (2006). Ruthenium Half‐Sandwich Complexes Bound to Protein Kinase Pim‐1. Angewandte Chemie International Edition. 45(10). 1580–1585. 203 indexed citations
16.
Atilla‐Gokcumen, G. Ekin, Douglas S. Williams, Howard Bregman, Nicholas Pagano, & Eric Meggers. (2006). Organometallic Compounds with Biological Activity: A Very Selective and Highly Potent Cellular Inhibitor for Glycogen Synthase Kinase 3. ChemBioChem. 7(9). 1443–1450. 94 indexed citations
17.
Bregman, Howard & Eric Meggers. (2006). Ruthenium Half-Sandwich Complexes as Protein Kinase Inhibitors:  An N-Succinimidyl Ester for Rapid Derivatizations of the Cyclopentadienyl Moiety. Organic Letters. 8(24). 5465–5468. 64 indexed citations
18.
Williams, Douglas S., et al.. (2005). Switching on a Signaling Pathway with an Organoruthenium Complex. Angewandte Chemie International Edition. 44(13). 1984–1987. 75 indexed citations
19.
Bregman, Howard, et al.. (2004). An Organometallic Inhibitor for Glycogen Synthase Kinase 3. Journal of the American Chemical Society. 126(42). 13594–13595. 109 indexed citations
20.
Handy, Scott T., Yanan Zhang, & Howard Bregman. (2004). A Modular Synthesis of the Lamellarins:  Total Synthesis of Lamellarin G Trimethyl Ether. The Journal of Organic Chemistry. 69(7). 2362–2366. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jasna Maksimoska Breakdown of academic impact, for papers by Joel C. Barrish Breakdown of academic impact, for papers by Benoı̂t Joseph Breakdown of academic impact, for papers by Brian E. Fink Breakdown of academic impact, for papers by Hsueh‐Yun Lee Breakdown of academic impact, for papers by Tao Lu Breakdown of academic impact, for papers by Wu Du Breakdown of academic impact, for papers by Pascale Moreau Breakdown of academic impact, for papers by Pier F. Cirillo Breakdown of academic impact, for papers by Ji‐Wang Chern
Rankless by CCL
2026